Full Length Research Paper
References
|
Alberti KGMM, Zimmet PZ (1998). For the WHO Consultation, definition, diagnosis and classification of diabetes mellitus and its complications; Part I: Diagnosis and classification of diabetes mellitus, Provisional report of a WHO consultation. Diabetic Medicine 15(7):539-553. |
|
|
Ames BN, Cathcart R, Schwiers E, Hochstein P (1981). Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proceedings of the National Academy of Sciences 78(11):6858-6862. |
|
|
Bouzid C, Smida H, Kacem A, Turki Z, Salem B, Slama BC (2011). L'insuffisance rénale chez des diabétiques de type 2 Tunisiens hospitalisés: fréquence et facteurs associés. Tunisie Médicale 89(1):10-15. |
|
|
Cheserek MJ, Shi Y, Le G (2018). Association of hyperuricemia with metabolic syndrome among university workers: sex and occupational differences. African Health Sciences 18(4):842-851. |
|
|
Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M (2004). Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4(1):1-9. |
|
|
Diouf NN, Boye O, Soumboundou M, Gueye MW, Sawaré E, Sylla-Niang M (2013). Evaluation de l'équilibre glycémique chez les sujets âgés présentant un diabète de type 2. Revue Médicale de Madagascar 3(2):269-272. |
|
|
El Bilbeisi A, Shab-Bidar S, Jackson D, Djafarian K (2017). The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A MetaAnalysis. Ethiopian Journal of Health Science 27(1):77-84. |
|
|
Fabbrini E, Serafini M, Baric IC, Hazen SL, Klein S (2014). Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 63(3):976-981. |
|
|
Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E (2004). Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired anti oxidative activity. The Journal of Clinical Endocrinololy and Metabolism 89(10):4963-4971. |
|
|
Hochberg MC, Smolen JS, Weinblatt ME, Weisman MH (2003). Rheumatology.3rd Ed.New York:Mosby. |
|
|
Huang G, Xu J, Zhang T, Cai L, Liu H, Yu X, Wu J (2020). Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu. Scientific Reports 10(1):1-7. |
|
|
Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M (2005). Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals. Arteriosclerosis Thrombosis and Vascular Biology 25(5):1038-1044. |
|
|
Ismail EM, Elbadawi N, Hassan D (2018). Uric Acid as a Biomarker of Metabolic Syndrome in Sudanese Adults. International Journal of Biochemistry and physiology 3(4):000137. |
|
|
Jeandel P, Kouda Zeh A (1987). Le diabète sucré au Cameroun. Etude prospective de 203 sujets. Médecine d'Afrique noire 34(10):861-873. |
|
|
Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005). Hyperuricemia induces endothelial dysfunction. Kidney International 67(5):1739-1742. |
|
|
Lee D, Choi WJ, Oh JS, Yi MK, Han SW, Yun JW, Han SH (2013). The relevance of hyperuricemia and metabolic syndrome and the effect of blood lead level on uricacid concentration in steel making workers. Annals of Occupational and Environmentalmedicine 25(1):1-7. |
|
|
Lee L, Sanders RA (2012). Metabolic Syndrome. Pediatrics in Review 33(10):459. |
|
|
Leyva F, Wingrove C, Godsland I, Stevenson J (1998). The glycolytic pathway to coronary heart disease: A hypothesis. Metabolism 47(6):657-662. |
|
|
Lorenzo C, Williams K, Hunt KJ, Haffner SM (2007). The National Cholesterol Education Program. Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30(1):8-13. |
|
|
Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck Ml (2003). Serum uricacid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42(4):474-480. |
|
|
Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y (1998). Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47(8):929-933. |
|
|
Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM, Frascerra S, Ciociaro D, Ferrannini E (1996). Effect of insulin on renal sodium and uricacid handling in essential hypertension. American Journal of Hypertension 9(8):746-752. |
|
|
Quinones Galvan A, Natali A, Baldi SI, Frascerra SI, Sanna GI, Ciociaro DE, Ferrannini E (1995). Effect of insulin on uricacidexcretion in humans. American Journal of Physiology-Endocrinology and Metabolism 268(1):1-5. |
|
|
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ (2007). Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. American Journal of Physiology-Cell Physiology 293:C584-C96. |
|
|
Siko A (1989). Prise en charge thérapeutique du diabète sucré chez l'adulte à l'hôpital Yalgado Ouédraogo : à propos de 65 cas [Thèse de doctorat en Médecine] Ouagadougou : Université de Ouagadougou Faculté de Médecine. |
|
|
Sung KC, Kim BJ, Kim BS, Kang JH, Lee MH (2004). In normoglycemic Koreans, insulin resistance and adipocity are independently correlated with high blood pressure. Circulation Journal 68(10):898-902. |
|
|
ViswanathanI M, Deepa M (2006). Syndrome métabolique dans les pays en développement. Diabetes Voice;51 (Numéro spécial):15-17. |
|
|
Vladimír K, Ružena S, Zuzana B, Tatiana S, Viktor B, Štefan B (2017). Monothérapie du syndrome métabolique expérimental : Etude des effets cardiovasculaires. Interdisciplinary Toxicology 10(3):86-92. |
|
|
Wanvoegbe FA, Agbodande KA, Alassani A, Gninkoun J, Kerekou A, Azon-Kouanou A, Amoussou-Guenou D, Djrolo F, Zannou M, Houngbe F (2017). Hyperuricémie chez les diabétiques de type 2 à Cotonou: prévalence et facteurs associés. Journal de la Société de Biologie Clinique 27:5-9. |
|
|
Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meig JB (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112(20):3066-3072. |
|
|
Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY (2005). Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circulation Journal 69(8):928-933. |
|
|
Zhang C, Liu R, Yuan J, Cui J, Hu F, Yang W, Zhang Y, Yang C, Qiao S (2016). Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy. Biology of Sex Differences 7(1):1-2. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
